The aim of these evidence-based guidelines is to present a consensus position from members of the Italian Unitary Society of Colon-Proctology (SIUCP: Società Italiana Unitaria di Colonproctologia) on the diagnosis and management of obstructed defecation syndrome (ODS), with the purpose of guiding physicians in the selection of the most appropriate treatment option. A panel of experts was appointed by the Board of the SIUCP to develop key questions addressing the main topics related to the management of ODS and to perform an accurate literature search for each topic, in order to provide evidence-based answers and to summarize them in structured statements. All clinical questions were discussed by the expert panel over multiple rounds using the Delphi approach, and consensus among the experts was achieved for each statement. The questions were formulated according to PICO (patients, intervention, comparison, outcome) criteria, and the statements were developed using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) methodology. In patients with ODS refractory to first-line medical therapy, rehabilitation may be considered as a therapeutic option, particularly in cases of dyssynergic defecation, whereas a surgical approach may be indicated in patients with a high symptom score and an Oxford prolapse grade system score ≥3 on defecography (using magnetic resonance imaging or another modality). Surgical options include stapled transanal rectal resection and ventral mesh rectopexy, eventually combined, respectively, with pelvic organ prolapse suspension and sacrocolpopexy in the presence of multicompartment pelvic prolapse. A transverse perineal support procedure may be considered in the presence of excessive perineal descent. In patients with recurrent symptoms after surgery, transanal irrigation may represent a useful therapeutic option.
Citations
Citations to this article as recorded by
Tailoring surgery for obstructed defecation and its evolution into ineffective defecation: a new staging of the syndrome and a site-specific decision algorithm Adolfo Renzi Annals of Coloproctology.2026; 42(3): 372. CrossRef
Physiological Optimization of Digital Self-Disimpaction Using a Step Stool: A Case Report Munehiro Yoshitomi Cureus.2026;[Epub] CrossRef
Transanal irrigation to treat refractory constipation: a short-term real-life study Danilo Consalvo, Gabrio Bassotti Internal and Emergency Medicine.2026;[Epub] CrossRef
Rectal cancer during pregnancy represents a clinical paradox in which the instinct to protect new life directly intersects with the urgency to preserve another. With an incidence of approximately 1 in 13,000 pregnancies, this rare condition challenges not only clinical decision-making but also the ethical and emotional dimensions of contemporary medical care. A 32-year-old primigravida at 26 weeks of gestation presented with rectal bleeding and was diagnosed with stage T4bN+M0 rectal adenocarcinoma. Despite the conventional recommendation of pregnancy termination in such circumstances, the patient expressed a strong desire to continue the pregnancy. A multidisciplinary team comprising colorectal surgeons, medical oncologists, radiation oncologists, and maternal-fetal medicine specialists developed a unified and coordinated treatment plan. The patient received neoadjuvant CAPOX (capecitabine [Xeloda] and oxaliplatin) chemotherapy during pregnancy, underwent cesarean delivery at 36 weeks of gestation, and subsequently completed postpartum chemoradiotherapy followed by curative laparoscopic oncologic resection. The child was delivered healthy, and the mother remained disease-free at a 5-year follow-up. This case demonstrates that life-threatening malignancy and ongoing pregnancy can coexist without compromise. Through carefully timed interventions, close cross-specialty collaboration, and respect for patient autonomy, both maternal and fetal outcomes were excellent. Within the evolving landscape of personalized cancer care, this case challenges outdated paradigms and reframes pregnancy not as a contraindication, but as a clinical variable that can be managed with precision and compassion. In addition to this illustrative case, we provide a focused review of the current literature to guide clinicians navigating this rare and complex clinical scenario.
Purpose Pilonidal sinus disease (PSD) is a chronic condition that primarily affects young adults. Sinus laser-assisted closure (SiLaC) has recently emerged as a minimally invasive alternative to conventional surgery, offering potential benefits in postoperative recovery and recurrence rates. This study evaluates the clinical outcomes, safety, and patient satisfaction associated with SiLaC.
Methods We conducted a retrospective analysis of prospectively collected data from 218 consecutive patients who underwent SiLaC for PSD between February 2023 and December 2024. Demographic characteristics, intraoperative parameters, postoperative complications, healing rates, and recurrence rates were examined. Pain and patient satisfaction were assessed using a standardized questionnaire.
Results The study cohort included 142 male patients (65.1%), with a mean age of 25.3±8.1 years. The mean operative time was 13.4±4.4 minutes, and all patients were discharged the same day. The overall complication rate was 15.1%, with most complications being minor abscesses (84.8% managed conservatively). Healing rates at 15, 30, and 45 days were 13.8%, 80.2%, and 98.1%, respectively, with a mean healing time of 26.1±9.8 days. Recurrence was observed in 8.7% of patients after a median follow-up of 11 months (range, 3–25 months), decreasing to 6.5% following a second SiLaC procedure. The mean pain score on postoperative day 1 was 2.8±2.4, and patient satisfaction at 30 days was 9.2 out of 10.
Conclusion SiLaC is a safe, effective, and well-tolerated minimally invasive treatment for PSD, associated with favorable short-term outcomes, rapid recovery, and low recurrence rates. Further research is needed to optimize treatment protocols and assess long-term outcomes.
Purpose Ileocecal tuberculosis (ICT) presents unique surgical challenges due to dense adhesions, distorted anatomy, and inflamed tissue planes. Although laparoscopic right hemicolectomy (LRH) is well established in colonic surgery, its application in ICT remains limited. We evaluated the feasibility and outcomes of the caudal tunneling with lateral colonic attachment preservation (CLAP) procedure, a modified laparoscopic technique designed to facilitate safer dissection in ICT.
Methods This single-center prospective cohort study was conducted between May 2016 and October 2023 at King George’s Medical University. Fifty-six adult patients with confirmed ICT underwent LRH using the CLAP technique. The procedure begins with retroperitoneal tunneling along Toldt fascia from the terminal ileum while preserving lateral colonic attachments until the final step. Intraoperative variables, perioperative outcomes, and complications were recorded. Patients were followed for 2 years to assess long-term outcomes.
Results The median age was 38 years, and 64.3% of patients were female. Dense adhesions were noted in 87.5% of cases. The mean operative time was 181 minutes (mean blood loss, 100±20 mL). Conversion to open surgery occurred in 3 patients (5.4%). Additional ports were required in 80.4%. Morbidities included prolonged ileus (10.7%), surgical site infection (5.4%), urinary tract infection (12.5%), and anastomotic leak (1.8%). There was no mortality. At 2-year follow-up, all patients demonstrated symptom resolution and weight gain, with 1 incisional hernia reported.
Conclusion The CLAP technique is a safe and feasible modification of LRH for ICT, enabling controlled retroperitoneal dissection and minimizing operative risk. Larger multicenter comparative studies are warranted.
Nadia Fathallah, Amine Antonin Alam, Maria Skoufou, Marie Lazareth, Lucas Spindler, Manuel Aubert, Eric Safa Far, Elise Pommaret, Amélie Barré, Mathilde Wisniewski, Sinon Kurt, Dior Marone, Vincent de Parades
Ann Coloproctol. 2026;42(2):198-207. Published online April 23, 2026
Purpose Minimally invasive techniques are increasingly applied in the management of pilonidal disease. While laser therapy is well established, radiofrequency (RF) represents a newer alternative with theoretical advantages. However, no prospective data have yet been published on its use. This study aimed to assess the safety, efficacy, and patient satisfaction associated with RF treatment for infected pilonidal sinus.
Methods We conducted a prospective, single-center pilot study including consecutive patients treated with RF between March and December 2023. The procedure was performed under spinal or general anesthesia in an outpatient setting using a radial RF probe (25 W, 4 MHz) following mechanical debridement. Patients were followed up at 15 days and at 1, 3, and 6 months. The primary endpoint was safety; secondary endpoints included healing rate, predictors of failure, postoperative pain, return to activities, and patient satisfaction.
Results Forty-four patients were enrolled (median age, 25.5 years; 31 men, 70.5%), of whom 38.6% had undergone previous surgery. The median operative time was 12 minutes. No major complications occurred, and minor early events were reported in 6.8% of cases. Complete healing at 6 months was achieved in 77.3% of patients. Failure and recurrence rates were 13.6% and 9.1%, respectively. A history of prior surgery significantly increased the risk of failure (odds ratio, 0.2; P=0.005). The median peak pain score was 2 out of 10, with a median duration of 2 days. Overall, 33 patients (75.0%) were very satisfied, and 40 (90.9%) stated they would undergo the procedure again or recommend it to others.
Conclusion RF appears to be a safe, minimally invasive outpatient treatment option for pilonidal disease, demonstrating promising efficacy, minimal postoperative pain, and high patient satisfaction.
Trial registration: ClinicalTrials.gov identifier: NCT05855733.
Purpose Antibiotic prophylaxis (AP) is a key component in preventing surgical site infections (SSIs). The existing gap between clinical guidelines and real-world practice may influence SSI rates. This study aimed to compare SSI rates between patients receiving guideline-concordant AP based on the 2020 Thailand guideline (group A) and those receiving broader-spectrum and/or prolonged prophylaxis (group B).
Methods We reviewed a database of adult patients who underwent elective colorectal resection between January 2022 and April 2024 at the largest university hospital in Thailand. SSIs were diagnosed using the US Centers for Disease Control and Prevention’s criteria. SSI rates between the 2 groups were compared, and factors associated with SSIs were determined.
Results This study included 1,584 patients, with an average age of 66 years, and 822 (51.9%) were male. The most common operation was anterior resection (n=470, 29.7%). A total of 1,030 patients (65.0%) underwent open surgery, and 228 patients (14.4%) had stoma formation. There were 405 patients (25.6%) in group A. Overall, SSIs occurred in 104 patients (6.6%): 69 incisional SSIs (4.4%) and 35 organ/space SSIs (2.2%). There was no significant difference in SSI rates between groups (group A vs. group B: 4.7% [95% confidence interval (CI), 2.9%–7.2%] vs. 7.2% [95% CI, 5.8%–8.8%]; P=0.078). Multivariate analysis identified 3 independent predictors of SSIs: hypoalbuminemia (odds ratio [OR], 2.53; 95% CI, 1.54–4.16; P<0.001), obesity (OR, 1.89; 95% CI, 1.08–3.32; P=0.026), and intraoperative blood loss greater than 400 mL (OR, 1.83; 95% CI, 1.06–3.16; P=0.031).
Conclusion There was no significant difference in SSI rates following colorectal surgery between patients receiving guideline-concordant AP and those receiving broader-spectrum and/or prolonged prophylaxis.
Purpose Adequate lymph node yield is crucial for accurate staging in colorectal cancer. This study aims to analyze clinical factors associated with lymph node retrieval in laparoscopic colorectal cancer surgery and to explore strategies that may enhance yield.
Methods We conducted a retrospective review of clinical, pathological, and surgical data from patients who underwent laparoscopic colorectal cancer resection between July 2019 and July 2024 at our institution. Patients were stratified by lymph node yield into 2 groups: <12 nodes (reduced yield) and ≥12 nodes (control). Univariate analyses were used to identify factors potentially affecting lymph node yield, and multivariate logistic regression was performed to determine independent risk factors for reduced yield.
Results A total of 639 patients (305 with rectal cancer and 334 with colon cancer) were included. Univariate analysis identified age (P=0.039), sex (P=0.029), neoadjuvant therapy (P<0.001), tumor location (P<0.001), invasion depth (P<0.001), lymphovascular invasion (P=0.028), and station-specific lymph node submission (P<0.001) as influential factors. Multivariate analysis revealed that preoperative neoadjuvant therapy, tumor location (non–right colon), shallow invasion depth (T1–T2), and lack of station-specific submission independently contributed to reduced lymph node yield (all P<0.05).
Conclusion This study highlights preoperative neoadjuvant therapy, tumor location, and invasion depth (T stage) as independent factors associated with reduced lymph node yield in laparoscopic colorectal cancer surgery. However, station-specific lymph node submission significantly increases yield and may help address inadequate retrieval. These findings suggest both predictive and interventional strategies to optimize lymph node harvest after surgery.
Purpose This study compared oncologic and perioperative outcomes between patients with locally advanced rectal cancer (LARC) treated with beyond total mesorectal excision (bTME) and those with pathologic stage III disease undergoing TME.
Methods A retrospective analysis was conducted using prospectively collected data from 580 LARC patients treated with curative-intent surgery over a 23-year period. Patients were categorized as those with clinical T4b tumors who underwent bTME with multivisceral resection (MVR) and those with pathologic stage III tumors treated with TME. Demographic, surgical, pathological, and oncologic outcomes were compared.
Results Circumferential resection margin (CRM) positivity was similar between the groups (5.3% vs. 3.6%, P=0.467). Postoperative complications occurred more often in the bTME group (28.9% vs. 16.6%, P=0.004), although major complications were comparable (P=0.812). Five-year local recurrence (10.5% vs. 9.3%, P=0.371), distant metastasis (19.7% vs. 21.4%, P=0.140), disease-free survival (64.4% vs. 66.2%, P=0.326), and overall survival (74.8% vs. 75.5%, P=0.464) demonstrated no significant differences. Within the bTME group, 32 patients (42.1%) underwent major MVR and 44 (57.9%) underwent minor MVR. CRM positivity (6.2% vs. 4.5%, P=0.999), local recurrence (12.5% vs. 9.1%, P=0.714), and distant metastasis (25.0% vs. 15.9%, P=0.388) rates were similar. Five-year disease-free survival (61.5% vs. 72.3%, P=0.454) and overall survival (68.5% vs. 74.8%, P=0.609) favored minor MVR, although the differences were not statistically significant.
Conclusion When negative circumferential margins are achieved, margin-driven bTME resections provide long-term oncologic outcomes comparable to standard TME in high-risk rectal cancer, although they are associated with higher overall complication rates.
Purpose The da Vinci Surgical System has led to major advances in robot-assisted colorectal surgery. Following its patent expiration, domestic alternatives such as the hinotori Surgical Robot System have been developed in Japan. However, clinical comparisons between the hinotori and the da Vinci Xi systems remain limited. This study aimed to compare the short-term outcomes of right-sided colon cancer surgeries performed with either system using propensity score matching.
Methods This retrospective study included 39 patients who underwent da Vinci–assisted surgery and 37 who underwent surgery using the hinotori system. Propensity score matching was performed using 7 covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, clinical T and N categories, and surgeon experience (≥100 prior robotic colorectal surgeries). To assess the robustness of the findings, inverse probability weighting was also applied using the same covariates. Surgical, postoperative, and pathological outcomes were evaluated.
Results After matching, 27 patients were included in each group. The hinotori group had significantly longer operative and console times (236 minutes vs. 191 minutes, P=0.001; 140 minutes vs. 90 minutes, P<0.001). No significant differences were observed in blood loss, complication rates, length of hospital stay, or lymph node harvest. No conversions or reoperations occurred. One readmission for ileus was noted in the da Vinci group, whereas none occurred in the hinotori group.
Conclusion Right colectomy assisted by the hinotori system demonstrated short-term outcomes equivalent to those of the da Vinci system, despite a prolonged operative time. Further prospective studies with larger sample sizes and longer follow-up are warranted.
Citations
Citations to this article as recorded by
Beyond the era of monopoly to diversity: new horizons in robotic colorectal cancer surgery Jeonghee Han Annals of Coloproctology.2026; 42(2): 149. CrossRef
KangDuo surgical robot KD-SR-01 versus da Vinci Xi in robot-assisted colorectal cancer resection: oncologic outcomes at three years in a multicenter randomized trial Zhanpeng Cen, Zhen Sun, Tianyi Ma, Donglin Du, Lai Xu, Junyang Lu, Zhengqiang Wei, Guiyu Wang, Yi Xiao Journal of Robotic Surgery.2026;[Epub] CrossRef
Purpose Stapled hemorrhoidopexy (SH) is commonly used to treat severe internal hemorrhoids and rectal mucosal prolapse associated with prolapsing hemorrhoids. A common complication of SH is SH site stricture (SHsS), which negatively affects quality of life. This study evaluated the efficacy and safety of low-dose triamcinolone acetonide (TA) injection at the SH site for the prevention of SHsS.
Methods Between 2020 and 2023, 1,023 patients underwent SH, with an average of 3.3 external hemorrhoids being excised per patient. The fluid mixture contained 40 mg of TA per 100 mL (0.4 mg/mL), with 5 mL (2 mg of TA) injected at the SH site and 2–3 mL (1.2 mg of TA) at each excisional hemorrhoidectomy site. The TA group (n=554; propensity score matching [PSM]-adjusted, n=375) received TA injections, whereas the non-TA group (n=469; after PSM, n=375) received conventional epinephrine injections. PSM was adjusted for age, sex, concurrent surgeries, botulinum toxin injection, and excisional hemorrhoidectomy frequency. Logistic regression models were used to analyze SHsS and reoperation rates.
Results SHsS rate was significantly lower in the TA group (2.9%) than in the non-TA group (16.0%). Furthermore, the reoperation rate was lower in the TA group (5.9%) than in the non-TA group (14.4%).
Conclusion Low-dose TA injections effectively prevent SHsS and reduce reoperation rates without increasing the risk of infection, providing a safe, cost-effective approach to improving surgical outcomes.